CBT Advisors Email Format
Biotechnology ResearchMassachusetts, United States2-10 Employees
CBT Advisors is a small consultancy based in Cambridge, Massachusetts, founded in 2003. It supports private biotechnology, life sciences, and medical device companies with storytelling and strategic guidance, including preparing the business sections needed for NASDAQ IPO filings. Its client work includes guiding firms through the process of public listings, with recent IPO assignments for Zentalis, Repare, Black Diamond, Pliant Therapeutics, iTeos, Legend Biotech, and Allovir. Earlier engagements encompassed a range of biopharma innovators such as CRISPR Therapeutics and Karuna Therapeutics. Operating in the biotechnology research sector, CBT Advisors provides focused advisory services intended to clarify a company's value proposition for investors.